Bioregenx (BRGX) Accumulated Expenses (2023 - 2026)
Bioregenx's quarterly Accumulated Expenses came in at $605510.0 in Q1 2026, up 31.71% year-on-year from $459732.0 in Q1 2025, and up 39.4% quarter-over-quarter from $434370.0 in Q4 2025.
Bioregenx has reported Accumulated Expenses for 4 years, with the latest figure at $605510.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 31.71% year-over-year to $605510.0; the trailing twelve-month figure through Mar 2026 stood at $605510.0 (up 31.71% YoY), and the FY2025 full-year result was $434370.0, up 2.38% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $605510.0, up from $434370.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $605510.0 in Q1 2026, with the low at $346677.0 in Q4 2023.
- Average Accumulated Expenses over 4 years is $424413.0, with a median of $414886.0 recorded in 2024.
- Year-over-year, Accumulated Expenses dropped 10.81% in 2025 and surged 31.71% in 2026.
- Tracing BRGX's Accumulated Expenses over 4 years: stood at $346677.0 in 2023, then rose by 22.38% to $424277.0 in 2024, then advanced by 2.38% to $434370.0 in 2025, then soared by 39.4% to $605510.0 in 2026.
- The last three Accumulated Expenses figures came in at $605510.0 (Q1 2026), $434370.0 (Q4 2025), and $380599.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Bioregenx | - | - | 348,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 605,510.00 |
| Dec 31, 2025 | 434,370.00 |
| Sep 30, 2025 | 380,599.00 |
| Jun 30, 2025 | 405,495.00 |
| Mar 31, 2025 | 459,732.00 |
| Dec 31, 2024 | 424,277.00 |
| Sep 30, 2024 | 383,906.00 |
| Jun 30, 2024 | 398,058.00 |
| Mar 31, 2024 | 321,897.00 |
| Dec 31, 2023 | 346,677.00 |